Consequently, IL-37 emerges as a promising immunoregulatory cytokine with significant potential in the context of atherosclerosis, particularly as an inflammation inhibitor that can shift the cytokine balance away from excessive inflammation. Here, IL37 is linked to atherosclerosis.